Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

House Republicans’ funding patch includes cutting funds for the Congressionally Directed Medical Research Programs, an agency ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...

Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...

In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...